Startup wants to advance minimally invasive device to resolve nasal obstruction
Spirox, based in Menlo Park, California, is traveling down the well-worn path of bringing a minimally invasive approach to complex surgery through a new device.
Spirox closes $45M Series C for its device used by Ear, Nose and Throat physicians
Nasal obstruction is a significant problem that effects more than three million Americans each year. Spirox is developing a minimally invasive device that would decrease the need for surgery.
Why Pharma Companies Should Look To Social Media For Better Patient InsightÂ
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.